<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">M. Arbyn</style></author><author><style face="normal" font="default" size="100%">Evert-Ben Van Veen</style></author><author><style face="normal" font="default" size="100%">Andersson, Kristin</style></author><author><style face="normal" font="default" size="100%">Bogers, Johannes</style></author><author><style face="normal" font="default" size="100%">Boulet, Gaëlle</style></author><author><style face="normal" font="default" size="100%">Bergeron, Christine</style></author><author><style face="normal" font="default" size="100%">von Knebel-Doeberitz, Magnus</style></author><author><style face="normal" font="default" size="100%">Dillner, Joakim</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Cervical cytology biobanking in Europe.</style></title><secondary-title><style face="normal" font="default" size="100%">Int J Biol Markers</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Int. J. Biol. Markers</style></alt-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Alphapapillomavirus</style></keyword><keyword><style  face="normal" font="default" size="100%">Biological Specimen Banks</style></keyword><keyword><style  face="normal" font="default" size="100%">Cervix Uteri</style></keyword><keyword><style  face="normal" font="default" size="100%">Dna</style></keyword><keyword><style  face="normal" font="default" size="100%">Europe</style></keyword><keyword><style  face="normal" font="default" size="100%">Female</style></keyword><keyword><style  face="normal" font="default" size="100%">Guidelines as Topic</style></keyword><keyword><style  face="normal" font="default" size="100%">Humans</style></keyword><keyword><style  face="normal" font="default" size="100%">Medical Record Linkage</style></keyword><keyword><style  face="normal" font="default" size="100%">Molecular Diagnostic Techniques</style></keyword><keyword><style  face="normal" font="default" size="100%">Papanicolaou Test</style></keyword><keyword><style  face="normal" font="default" size="100%">Papillomavirus Infections</style></keyword><keyword><style  face="normal" font="default" size="100%">Papillomavirus Vaccines</style></keyword><keyword><style  face="normal" font="default" size="100%">REGISTRIES</style></keyword><keyword><style  face="normal" font="default" size="100%">Rna</style></keyword><keyword><style  face="normal" font="default" size="100%">specimen handling</style></keyword><keyword><style  face="normal" font="default" size="100%">Terminology as Topic</style></keyword><keyword><style  face="normal" font="default" size="100%">Uterine Cervical Neoplasms</style></keyword><keyword><style  face="normal" font="default" size="100%">Uterine Cervicitis</style></keyword><keyword><style  face="normal" font="default" size="100%">Vaginal Smears</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2010</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2010 Jul-Sep</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">25</style></volume><pages><style face="normal" font="default" size="100%">117-25</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p&gt;A cervical cytology biobank (CCB) is an extension of current cytopathology laboratory practice consisting in the systematic storage of Pap smears or liquid-based cytology samples from women participating in cervical cancer screening with the explicit purpose to facilitate future scientific research and quality audit of preventive services. A CCB should use an internationally agreed uniform cytology terminology, be integrated in a national or regional screening registry, and be linked to other registries (histology, cancer, vaccination). Legal and ethical principles concerning personal integrity and data safety must be respected strictly. Biobank-based studies require approval of ethical review boards. A CCB is an almost inexhaustible resource for fundamental and applied biological research. In particular, it can contribute to answering questions on the natural history of HPV infection and HPV-induced lesions and cancers, screening effectiveness, exploration of new biomarkers, and surveillance of the short- and long-term effects of the introduction of HPV vaccination. To understand the limitations of CCB, more studies are needed on the quality of samples in relation to sample type, storage procedures, and duration of storage.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">3</style></issue><custom1><style face="normal" font="default" size="100%">http://www.ncbi.nlm.nih.gov/pubmed/20872354?dopt=Abstract</style></custom1></record></records></xml>